IP Library Granted Patent US 12,158,465
Granted Patent B2
US 12,158,465 · App. 16/607,233 · Granted Dec 3, 2024

Device and method for sample isolation

Inventors: Jeffrey Kenneth Horton (Cardiff, GB); Peter James Tatnell (Cardiff, GB); Alan Pierce (Cardiff, GB); Alexander Schenk (Dassel, DE); Rebecca Ngaire Fullerton (Bulwark, GB)
Assignee: GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD
G01N33/538B01D69/144C07K1/34C07K1/36G01N33/54393
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,158,465
App. No.
16/607,233
Granted
Dec 3, 2024
Kind
B2
Abstract

The present invention relates to a device and method for sample preparation and collection. More closely the invention relates to a device to isolate DNA, RNA and proteins or other biomolecules in one single step from the same undivided sample.

Claims (10)

1. A device for simultaneous protein and nucleic acid separation comprising a column with an inlet and an outlet, wherein the column is provided with at least three types of membranes directly stacked on top of each other inside the column, wherein the device comprises an upper membrane A which is a sieving membrane configured to collect course materials, a middle membrane B which is a silica, glass fibre or quartz fibre membrane for nucleic acid separation, and a lower membrane C which is a ligand provided membrane for protein separation.

2. The device according to claim 1 , wherein the order in which membranes B and C are arranged in the column may be reversed.

3. The device according to claim 1 , wherein one or more of each type of the membranes A, B and C are provided.

4. The device according to claim 1 , wherein one of each kind of the membranes A, B and C is provided.

5. The device according to claim 1 , wherein the sieving membrane A excludes particles larger than 0.10 μm.

6. The device according to claim 1 , wherein the protein separating membrane C is provided with an affinity ligand, ion exchange ligand or hydrophobic interaction ligand.

7. A method for simultaneous protein and nucleic acid separation, comprising adding a sample to the device according to claim 1 and eluting proteins and nucleic acids separately.

8. The device according to claim 3 , wherein 1-10 of each of the membranes A, B and C are provided.

9. The device according to claim 5 , wherein the sieving membrane A excludes particles larger than 0.22 μm.

10. The device according to claim 5 , wherein the sieving membrane A excludes particles larger than 0.45 μm.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2020
From: GE HEALTHCARE UK LIMITED
To: GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD
Reel/Frame 053653/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2019
From: HORTON, JEFFREY KENNETH; FULLERTON, REBECCA NGAIRE; TATNELL, PETER JAMES; SCHENK, ALEXANDER; PIERCE, ALAN STUART
To: GE HEALTHCARE UK LIMITED
Reel/Frame 050790/0103 →